Èñòîðèÿ èíñòèòóòà
Íàöèîíàëüíûé èíñòèòóò ôòèçèàòðèè è
ïóëüìîíîëîãèè èì Ô.Ã. ßíîâñêîãî

Ïîñåòèòå íàøó ñòðàíèöóâ Facebook

 

Êëèíèêà
Êîíòàêòû

Ïåðåõîä íà òèòóëüíóþ ñòðàíèöóÏîèñê ïî ñàéòó

Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë

Îá èíñòèòóòå:

èñòîðèÿ,

îáùèå ïîëîæåíèÿ,

ñòðóêòóðà,

íàó÷íàÿ äåÿòåëüíîñòü,

ïëàíû ÍÈÐ,

ëå÷åáíî-äèàãíîñòè÷åñêàÿ ðàáîòà,

âåäóùèå ó÷åíûå

Íîâîñòè:

íîâèíêè íà ñàéòå

Íàøè èçäàíèÿ:

"Óêðàèíñêèé ïóëüìîíîëîãè÷åñêèé æóðíàë" (ÓÏÆ),
"Óêðàèíñêèé õèìèîòåðàïåâòè÷åñêèé æóðíàë" (ÓÕÆ),
"Àñòìà è àëëåðãèÿ"

Îðèãèíàëüíûå ñòàòüè:

îðèãèíàëüíûå íàó÷íûå ñòàòüè, ðàíåå íèãäå íå ïóáëèêîâàâøèåñÿ

Íîâîââåäåíèÿ:

ìåòîäè÷åñêèå ðåêîìåíäàöèè, èíôîðìàöèîííûå ïèñüìà,
âåäîìñòâåííûå èíñòðóêöèè,
íîâîââåäåíèÿ, ìîíîãðàôèè

Ïàòåíòû:

ïàòåíòû è àâòîðñêèå ñâèäåòåëüñòâà èíñòèòóòà

Îò÷åòû î ÍÈÐ:

ðåôåðàòû çàêîí÷åííûõ íàó÷íî-èññëåäîâàòåëüñêèõ ðàáîò

Ïîäãîòîâêà êàäðîâ:

àñïèðàíòóðà,

êëèíè÷åñêàÿ îðäèíàòóðà,
êóðñû èíôîðìàöèè è ñòàæèðîâêè,

â ïîìîùü àñïèðàíòó è ñîèñêàòåëþ

Íàó÷íûå ôîðóìû:

ðåçîëþöèè è îáðàùåíèÿ ñúåçäîâ, êîíôåðåíöèé, ñîâåùàíèé...

Âèðòóàëüíûå êîíôåðåíöèè:

âîïðîñû è îòâåòû ïî ïðîáëåìàì çàáîëåâàíèé îðãàíîâ äûõàíèÿ

Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâ:

îáçîðû ëèòåðàòóðû, ñòàòèñòè÷åñêàÿ èíôîðìàöèÿ, íîâîå â ëå÷åíèè òóáåðêóëåçà è íåñïåöèôè÷åñêèõ çàáîëåâàíèé ëåãêèõ...

Èíôîðìàöèÿ äëÿ íàñåëåíèÿ:

ïîëåçíàÿ èíôîðìàöèÿ î çàáîëåâàíèÿõ ëåãêèõ, èõ ïðîôèëàêòèêå è ëå÷åíèè

2016. - ¹ 2.
Ç̲ÑÒ / ÑÎÄÅÐÆÀÍÈÅ / CONTENTS

ÎÐÈòÍÀËÜͲ ÑÒÀÒÒ² / ORIGINALS
 

Þ. ². Ôåùåíêî, Â. Ì. Ìåëüíèê, Â. Ã. Ìàòóñåâè÷, ². Î. Íîâîæèëîâà, Î. Ð. Òàðàñåíêî, ². Â. Áóøóðà, À. Ì. Ïðèõîäüêî
ÅÔÅÊÒÈÂͲÑÒÜ ² ÍÅÄÎ˲ÊÈ ÔÓÍÊÖ²ÎÍÓÂÀÍÍß ÏÐÎÒÈÒÓÁÅÐÊÓËÜÎÇÍί ÑËÓÆÁÈ Â ÓÊÐÀ¯Í²

®

Yu. I. Feshchenko, V. M. Melnyk, V. G. Matusevych, I. O. Novozhylova, E. R. Tarasenko, I. V. Bushura, A. N. Prihodko
THE EFFECTIVENESS OF THE TB SERVICE OPERATION IN UKRAINE

 

 

Ò. Î. Ïåðöåâà, Ë. ². Êîíîïê³íà, Þ. Â. Ãóáà
ÏÎвÂÍßËÜÍÈÉ ÀÍÀË²Ç Ê˲ͲÊÎ-ÔÓÍÊÖ²ÎÍÀËÜÍÎÃÎ ÒÀ ÏÑÈÕ²×ÍÎÃÎ ÑÒÀÒÓÑÓ ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ

®

T. Î. Pertseva, L. I. Konopkina, Y. V. Guba
COMPARATIVE ANALYSIS OF CLINICAL, FUNCTIONAL AND MENTAL STATUS OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

 

Ã. Ë. Ãóìåíþê, Å. À. Ìåðåíêîâà
ÏÅÐÑÏÅÊÒÈÂÛ ÏÐÈÌÅÍÅÍÈß ÌÅÒÎÒÐÅÊÑÀÒÀ  ËÅ×ÅÍÈÈ ÁÎËÜÍÛÕ ÑÀÐÊÎÈÄÎÇÎÌ ÎÐÃÀÍΠÄÛÕÀÍÈß

®

G. L. Gumeniuk, E. A. Merenkova
PERSPECTIVES OF METHOTREXATE USE IN TREATMENT OF PULMONARY SARCOIDOSIS PATIENTS

 

Å. Î. Êðàõìàëîâà, Ã. Ä. Ôàäååíêî, Å. Â. Èçìàéëîâà
ÑÂßÇÜ ÝÍÄÎÑÊÎÏÈ×ÅÑÊÈÕ ÏÐÎßÂËÅÍÈÉ ÃÀÑÒÐÎÝÇÎÔÀÃÅÀËÜÍÎÉ ÐÅÔËÞÊÑÍÎÉ ÁÎËÅÇÍÈ Ñ ÓÐÎÂÍÅÌ ÌÅËÀÒÎÍÈÍÀ È ÒßÆÅÑÒÜÞ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÀÏÍÎÝ ÑÍÀ

®

E. O. Krakhmalova, G. D. Fadieienko, E. V. Izmailova
RELATIONSHIP BETWEEN ENDOSCOPIC MANIFESTATIONS OF GASTROESOPHAGEAL REFLUX DISEASE, LEVEL OF MELATONIN AND SEVERITY OF OBSTRUCTIVE SLEEP APNEA

 

 

ÌÀÒÅвÀËÈ ÍÀÓÊÎÂÎ-ÏÐÀÊÒÈ×Íί ÊÎÍÔÅÐÅÍÖ²¯ “ÀÊÒÓÀËÜͲ ÏÈÒÀÍÍß ÂÅÄÅÍÍß ÕÂÎÐÈÕ ÍÀ ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ÍÀ ÑÒÀÖ²ÎÍÀÐÍÎÌÓ ÒÀ ÀÌÁÓËÀÒÎÐÍÎÌÓ ÅÒÀÏÀÕ”31 ÁÅÐÅÇÍß 2016 ÐÎÊÓ / PROCEEDINGS OF SCIENTIFIC CONFERENCE“MANAGEMENT OF DRUG-RESISTANT TUBERCULOSIS PATIENTS AT HOSPITAL AND IN OUT-PATIENT SETTINGS”, MARCH 31, 2016

 

Þ. ². Ôåùåíêî, Í. À. Ëèòâèíåíêî, Ì. Â. Ïîãðåáíà, Þ. Î. Ñåíüêî, Â. Â. Äàâèäåíêî
ÎÁ¥ÐÓÍÒÓÂÀÍÍß ÑÊÎÐÎ×ÅÍÈÕ ÐÅÆÈ̲ ղ̲ÎÒÅÐÀϲ¯ ÄËß ÕÂÎÐÈÕ ÍÀ ÌÐÒÁ ÇÀ ²Ò×ÈÇÍßÍÈÌ ÄÎѲÄÎÌ

®

Yu. I. Feshchenko, N. A. Lytvynenko, M. V. Pogrebna, Yu. O. Senko, V. V. Davydenko
RATIONALE FOR SHORTENING THE LENGTH OF MDR-TB CHEMOTHERAPY COURSE ACCORDING TO DOMESTIC EXPERIENCE
 

Þ. ². Ôåùåíêî, Â. Ì. Ìåëüíèê, Â. Ã. Ìàòóñåâè÷, ². Î. Íîâîæèëîâà, ². Â. Áóøóðà, À. Ì. Ïðèõîäüêî
ÏÐÎÁËÅÌÀ ˲ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÒÓÁÅÐÊÓËÜÎÇ ÍÀ Ò˲ ÐÅÑÒÐÓÊÒÓÐÈÇÀÖ²¯ ÏÐÎÒÈÒÓÁÅÐÊÓËÜÎÇÍί ÑËÓÆÁÈ Â ÓÊÐÀ¯Í²

®

Yu. I. Feshchenko, V. M. Melnyk, V. G. Matusevich, I. O. Novozhylova, I. V. Bushura, A. M. Prikhodko
MANAGEMENT OF TUBERCULOSIS PATIENTS IN SITUATION OF RESTRUCTURING OF ANTI-TB SERVICE IN UKRAINE
 

À. È. Áàðáîâà
ÑÎÂÐÅÌÅÍÍÛÅ ÏÎÄÕÎÄÛ Ê ÄÈÀÃÍÎÑÒÈÊÅ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÎÃÎ ÒÓÁÅÐÊÓËÅÇÀ

®

A. I. Barbova
CURRENT APPROACHES TO DIAGNOSIS OF MULTIDRUG-RESISTANT TUBERCULOSIS
 

Í. Â. Ãðàíê³íà, Í. À. Ëèòâèíåíêî
8-̲Ñß×ÍÀ ²ÍÒÅÍÑÈÂÍÀ ÔÀÇÀ ղ̲ÎÒÅÐÀϲ¯ ÏÐÈ Ë²ÊÓÂÀÍͲ ÕÂÎÐÈÕ ÍÀ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ: ÍÀÑʲËÜÊÈ ÖÅ ÍÅÎÁÕ²ÄÍÎ?

®

N. V. Grankina, N. A. Lytvynenko
8-MONTHS CHEMOTHERAPY INTENSIVE PHASE IN TREATMENT OF MDR-TB PATIENTS: IS IT REALLY NECESSARY?
 

 

Gunta Dravniece
INTRODUCTION OF NEW DRUGS AND SHORTENED REGIMENS FOR MDR-TB TREATMENT

 

². Ô. ²ëü¿íñüêà, Î. Ì. Ðåêàëîâà, Þ. Î. Ìàò⳺íêî, Î. Ð. Ïàíàñþêîâà
ÎÁÃÐÓÍÒÓÂÀÍÍß ÏÐÈÍÖÈϲ ÐÀÖ²ÎÍÀËÜÍί ²ÍÒÅÐÔÅÐÎÍÎÒÅÐÀϲ¯ Ó ÕÂÎÐÈÕ ÍÀ ÄÅÑÒÐÓÊÒÈÂÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

I. F. Iliinska, O. M. Rekalova, Yu. O. Matviienko, O. R. Panasiukova
RATIONALE FOR RATIONAL INTERFERON THERAPY IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS
 

Ì. Ì. Êóæêî, Î. Â. Àâðàì÷óê, Ë. Ì. Ïðîöèê
Ê˲Ͳ×ÍÀ ÅÔÅÊÒÈÂͲÑÒÜ ÃÀÒÈÔËÎÊÑÀÖÈÍÓ Â ÍÒÅÍÑÈÂÍÓ ÔÀÇÓ ÏÐÎÒÈÒÓÁÅÐÊÓËÜÎÇÍί ÒÅÐÀϲ¯ Ó ÕÂÎÐÈÕ ÍÀ ÂÏÅÐØŠIJÀÃÍÎÑÒÎÂÀÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

M. M. Kuzhko, O. V. Avramchuk, L. M. Protsyk
CLINICAL EFFICACY OF GATIFLOXACIN IN INTENSIVE PHASE OF CHEMOTHERAPY IN NEWLY DETECTED PULMONARY TUBERCULOSIS PATIENTS
 

Ì. Ì. Êóæêî, Î. Þ. Ãðèá
Ê˲ͲÊÎ-ÐÅÍÒÃÅÍÎËÎò×ÍÀ ÊÀÐÒÈÍÀ ÐÅÖÈÄȲ ÒÓÁÅÐÊÓËÜÎÇÓ ËÅÃÅÍÜ Ç Ð²ÇÍÈÌ Ð²ÂÍÅÌ ÑÒ²ÉÊÎÑÒ² ÄÎ ÏÐÎÒÈÒÓÁÅÐÊÓËÜÎÇÍÈÕ ÏÐÅÏÀÐÀÒ²Â

®

M. M. Kuzko, O. Yu. Gryb
CLINICAL SIGNS AND RADIOLOGICAL FINDINGS IN TUBERCULOSIS RELAPSE PATIENTS WITH DIFFERENT LEVELS OF DRUG RESISTANCE
 

Í. À. Ëèòâèíåíêî, Ã. Î. Âàðèöüêà
Ê˲Ͳ×ÍÀ ÄÅÌÎÍÑÒÐÀÖ²ß ÂÈÏÀÄʲ ÑÊÎÐÎ×ÅÍÎÃÎ ÊÓÐÑÓ Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ, IJÀÃÍÎÑÒÎÂÀÍÈÉ ÌÎËÅÊÓËßÐÍÎ-ÃÅÍÅÒÈ×ÍÈÌ ÌÅÒÎÄÎÌ

®

N. A. Lytvynenko, G. O. Varytska
CLINICAL DEMONSTRATION OF CASES WITH REDUCED COURSE OF TREATMENT IN PATIENTS WITH MULTI-RESISTANT TUBERCULOSIS, DIAGNOSED USING MOLECULAR-GENETIC METHOD
 

 

Þ. À. Ìàò⳺íêî, Î. Ì. Ðåêàëîâà, Î. Ð. Ïàíàñþêîâà, Ñ. Ã. ßñèð, Ñ. Î. ×åðåíüêî, Í. À. Ëèòâèíåíêî, Î. À. Ðåâà
ÇÀÑÒÎÑÓÂÀÍÍß ÁÀÊÒÅвÀËÜÍÎÃÎ ÏÅÏÒÈÄÎÃ˲ÊÀÍÓ Ç ÌÅÒÎÞ ÊÎÐÅÊÖ²¯ ÑÈÑÒÅÌÈ ÃÀÌÀ-²ÍÒÅÐÔÅÐÎÍÓ Ó ÕÂÎÐÈÕ ÍÀ ÄÅÑÒÐÓÊÒÈÂÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ ËÅÃÅÍÜ

®

Yu. A. Matviienko, O. M. Rekalova, O. R. Panasiukova, S. G. Iasyr, S. O. Cherenko, N. A. Lytvynenko, O. A. Reva
USE OF BACTERIAL PEPTIDOGLYCAN FOR CORRECTION OF GAMMA-INTERFERON SYSTEM IN PATIENTS WITH DESTRUCTIVE PULMONARY TUBERCULOSIS
 

Î. Ä. ͳêîëàºâà
ÏÐÎÁËÅÌÈ ÂÅÄÅÍÍß ÂÈÏÀÄÊÓ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÎÃÎ ÒÓÁÅÐÊÓËÜÎÇÓ Ó Â²Ë-²ÍÔ²ÊÎÂÀÍÈÕ

®

O. D. Nikolaieva
CHALLENGES IN MANAGEMENT OF TUBERCULOSIS CASE IN HIVINFECTED PATIENTS
 

Ì. Ñ. Îïàíàñåíêî, Î. Â. Òåðåøêîâè÷, Á. Ì. Êîí³ê, Ì. ². Êàëåíè÷åíêî
ÌÎÆËÈÂÎÑÒ² Õ²ÐÓÐò×ÍÎÃΠ˲ÊÓÂÀÍÍß ÌÓËÜÒÈÐÅÇÈÑ ÒÅÍÒÍÎÃÎ ÄÅÑÒÐÓÊÒÈÂÍÎÃÎ ÒÓÁÅÐÊÓËÜÎÇÓ ËÅÃÅÍÜ

®

M. S. Opanasenko, O. V. Tereshkovich, B. M. Konik, M. I. Kalenichenko
SURGICAL MANAGEMENT OF MULTI-RESISTANT DESTRUCTIVE PULMONARY TUBERCULOSIS
 

Ë. Ä. Òîäîð³êî, ². Î. Ñåì’ÿí³â, Î. Â. ϳäâåðáåöüêà, ². Â. ªðåì÷óê, ². ². Ãàâðèø
ÎÖ²ÍÊÀ ÅÔÅÊÒÈÂÍÎÑÒ² ÓÄÎÑÊÎÍÀËÅÍÎÃΠ˲ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ղ̲ÎÐÅÇÈÑÒÅÍÒÍÈÉ ÒÓÁÅÐÊÓËÜÎÇ Ç ÓÐÀÕÓÂÀÍÍßÌ ÏÎ˲ÌÎÐÔ²ÇÌÓ ÃÅͲ GSTT1 I GSTM1 ÑÒÀÍÓ ÊÈØÊÎÂÎÃÎ ÂÑÌÎÊÒÓÂÀÍÍß ÒÀ ÑÒÓÏÅÍß ÄÈÑÁ²ÎÇÓ

®

L. D. Todoriko, I. O. Semianiv, O. V. Pidverbetska, I. V. Ieremchuk, I. I. Gavrysh
EVALUATION OF EFFECTIVENESS OF IMPROVED THERAPY OF PATIENTS WITH CHEMO-RESISTANT TUBERCULOSIS, CONSIDERING GSTT1 AND GSTM1 GENES POLYMORPHISM, INTESTINAL ABSORPTION AND GRADE OF DYSBIOSIS
 

Î. Ï. ×îáîòàð, Í. À. Ëèòâèíåíêî
Ê˲Ͳ×ÍÀ ÄÅÌÎÍÑÒÐÀÖ²ß ÍÎÂÈÕ ÂÈÏÀÄʲ ÌÓËÜÒÈÐÅÇÈÑÒÅÍÒÍÎÃÎ ÒÓÁÅÐÊÓËÜÎÇÓ ÒÀ ÒÓÁÅÐÊÓËÜÎÇÓ ²Ç ÏÐÅÐÎÇØÈÐÅÍÎÞ ÐÅÇÈÑÒÅÍÒͲÑÒÞ, Ê˲Ͳ×ÍÅ ÎÁÃÐÓÍÒÓÂÀÍÍß ÑÊÎÐÎ×ÅÍÈÕ ÑÕÅÌ Õ²Ì²ÎÒÅÐÀϲ¯

®

O. P. Chobotar, N. A. Lytvynenko
CLINICAL DEMONSTRATION OF NEW CASES OF MULTI-RESISTANT AND PRE-EXTENDED RESISTANT TUBERCULOSIS; CLINICAL JUSTIFICATION FOR REDUCED REGIMENS OF CHEMOTHERAPY
 

 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

²ÊÒÎÐ ÃÅÎÐòÉÎÂÈ× Ì’ßÑͲÊÎÂ
®

VIKTOR G. MIASNIKOV
 

ÌÀÒÅвÀËÈ V ÍÀÓÊÎÂÎ-ÏÐÀÊÒÈ×Íί ÊÎÍÔÅÐÅÍÖ²¯ “ÀÊÒÓÀËÜͲ ÏÐÎÁËÅÌÈ Ë²ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÕÐÎͲ×ÍÅ ÎÁÑÒÐÓÊÒÈÂÍÅ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ” 14 ʲÒÍß 2016 ÐÎÊÓ / PROCEEDINGS OF 5TH SCIENTIFIC CONFERENCE “ACTUAL PROBLEMS OF MANAGEMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE”, APRIL 14, 2016

 

Ì. Ì. Îñòðîâñüêèé
ÏÀÒÎÃÅÍÅÒÈ×ÍÅ ÎÁ¥ÐÓÍÒÓÂÀÍÍß ÇÀÑÒÎÑÓÂÀÍÍß Ò²ÎÒÐÎÏ²Þ Â Ë²ÊÓÂÀÍͲ ÕÎÇË ÒÀ ÀÑÒÌÈ

®

M. M. Ostrovskiy
PATHOGENESIS RATIONALE FOR USE OF THIOTROPIUM IN MANAGEMENT OF COPD AND ASTHMA
 

Þ. Ì. Ìîñòîâîé, Í. Ñ. Ñëåï÷åíêî, À. Î. Äîâãàíü
Ò²ÎÒÐÎÏ²É Ó «ÊÂÀÄÐÀÒ²» ÕÎÇË ÒÀ ÍÀ «ÙÀÁËßÕ» ÁÐÎÍÕ²ÀËÜÍί ÀÑÒÌÈ

®

Yu. M. Mostovoy, N. S. Slepchenko, A. O. Dovgan
THIOTROPIUM IN QUADRANT OF COPD AND STAIRS OF ASTHMA
 

Ë. È. Êîíîïêèíà
ÝÂÎËÞÖÈß ÄÎÑÒÀÂÎ×ÍÛÕ ÓÑÒÐÎÉÑÒÂ

®

L. I. Konopkina
EVOLUTION OF DELIVERY DEVICES
 

Ì. Ì. Îñòðîâñüêèé
ÏÎIJÉÍÀ ÁÐÎÍÕÎÄÈËÀÒÀÖ²ß – Íβ ÌÎÆËÈÂÎÑÒ² ˲ÊÓÂÀÍÍß ÕÎÇË. ÄÎÖ²ËÜͲÑÒÜ ÊÎÌÁ²ÍÓÂÀÍÍß ÁÐÎÍÕÎÄÈËÀÒÀÒÎвÂ

®

M. M. Ostrovskiy
DUAL BRONCHODILATOR THERAPY: NOVEL POSSIBILITIES IN COPD MANAGEMENT. FEASIBILITY OF BRONCHODILATORS COMBINING
 

Ä. Ì. Áîéêî
ÏÎIJÉÍÀ ÁÐÎÍÕÎÄÈËÀÒÀÖ²ÉÍÀ ÒÅÐÀÏ²ß Â ÏÎÊÐÀÙÅÍͲ ÔÓÍÊÖ²¯ ËÅÃÅÍÜ Ó ÏÀÖ²ªÍÒ²Â Ç ÕÎÇË

®

D. M. Boiko
DUAL BRONCHODILATOR THERAPY FOR IMPROVING LUNG FUNCTION IN COPD PATIENTS
 

ß. À. Äçþáëèê
ÍÎÂÛÅ ÂÎÇÌÎÆÍÎÑÒÈ ÒÅÐÀÏÈÈ ÁÎËÜÍÛÕ ÕÎÇË Ñ ÐÀÇËÈ×ÍÛÌ ÐÈÑÊÎÌ ÎÁÎÑÒÐÅÍÈÉ

®

Ya. A. Dziublyk
NOVEL THERAPEUTIC OPTIONS IN COPD PATIENTS WITH DIFFERENT RISK OF EXACERBATIONS
 

Þ. Ì. Ìîñòîâîé, Ë. Â. Ðàñïóò³íà, Ä. Â. ijäåíêî, Í. Â. ×åðåï³é
IJÀËÎà ˲ÊÀÐß ÇÀÃÀËÜÍί ÏÐÀÊÒÈÊÈ ² ÏÀÖ²ªÍÒÀ Ç ÕÎÇË

®

Yu. M. Mostovoy, L. V. Rasputina, D. V. Didenko, N. V. Cherepiy
GENERAL PRACTITIONER’S DIALOG WITH A COPD PATIENT
 

Ë. È. Êîíîïêèíà
ÏÎÄÕÎÄÛ Ê ËÅ×ÅÍÈÞ ÁÎËÜÍÛÕ ÕÐÎÍÈ×ÅÑÊÈÌ ÎÁÑÒÐÓÊÒÈÂÍÛÌ ÇÀÁÎËÅÂÀÍÈÅÌ ËÅÃÊÈÕ Â ÇÀÂÈÑÈÌÎÑÒÈ ÎÒ ÔÅÍÎÒÈÏÎÂ

®

L. I. Konopkina
APPROACHES TO THE TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE DEPENDING ON PHENOTYPES
 

Í. Í. Îñòðîâñêèé
ÕÎÇË: ÏÓÒÜ Ê ÏÅÐÑÎÍÀËÈÇÎÂÀÍÍÎÉ ÌÅÄÈÖÈÍÅ

®

N. N. Ostrovskiy
COPD: THE WAY TO PERSONALIZED MEDICINE
 

Þ. Ì. Ìîñòîâîé, Î. Â. Áóãàé÷óê
ÇÀÃÎÑÒÐÅÍÍß ÕÎÇË: ̲ÆÍÀÐÎÄÍÈÉ ÏÎÃËßÄ, ÓÊÐÀ¯ÍÑÜÊÈÉ ÂÈÁ²Ð

®

Yu. M. Mostovoy, O. V. Bugaichuk
EXACERBATION OF COPD: INTERNATIONAL POINT OF VIEW, UKRAINIAN CHOICE
 

Î. Ñ. Òîëîõ
ÑÓ×ÀÑͲ ϲÄÕÎÄÈ ÄΠ˲ÊÓÂÀÍÍß ÕÂÎÐÈÕ ÍÀ ÕÎÇË

®

O. S. Tolokh
CURRENT APPROACHES TO THE TREATMENT OF COPD PATIENTS
 

Ì. Ì. Îñòðîâñüêèé
ÌÎÆËÈÂÎÑÒ² ÏÐÎÒÈÇÀÏÀËÜÍί ÒÅÐÀϲ¯ Ó Ë²ÊÓÂÀÍͲ ÒÀ ÏÐÎÔ²ËÀÊÒÈÖ² ÇÀÃÎÑÒÐÅÍÜ ÕÐÎͲ×ÍÎÃÎ ÎÁÑÒÐÓÊÒÈÂÍÎÃÎ ÇÀÕÂÎÐÞÂÀÍÍß ËÅÃÅÍÜ

®

M. M. Ostrovskiy
EFFECTIVENESS OF ANTI-INFLAMMATORY THERAPY IN PROPHYLAXIS OF COPD EXACERBATIONS
 

È. Â. Ãîãóíñêàÿ, Î. À. Íàóìîâà, Ò. Þ. Õîëîäåíêî
ÍÎÂÛÅ ÍÀÏÐÀÂËÅÍÈß Â ÄÈÀÃÍÎÑÒÈÊÅ È ËÅ×ÅÍÈÈ ÀËËÅÐÃ×ÅÑÊÈÕ ÇÀÁÎËÅÂÀÍÈÉ ÂÅÐÕÍÈÕ ÄÛÕÀÒÅËÜÍÛÕ ÏÓÒÅÉ

®

I. V. Gogunskaia, O. A. Naumova, T. Yu. Kholodenko
NEW PROSPECTS IN DIAGNOSING AND MANAGEMENT OF ALLERGIC DISEASES OF UPPER RESPIRATORY TRACT
 

Å. Í. Îõîòíèêîâà
ÎÑÎÁÅÍÍÎÑÒÈ ÐÅÑÏÈÐÀÒÎÐÍÎÉ ÀËËÅÐÃÈÈ Ó ÄÅÒÅÉ ÏÎÄÐÎÑÒÊÎÂÎÃÎ È ÞÍÎØÅÑÊÎÃÎ ÂÎÇÐÀÑÒÀ È ÂÎÇÌÎÆÍÎÑÒÈ ÑÎÂÐÅÌÅÍÍÎÉ ÏÐÎÒÈÂÎÂÎÑÏÀËÈÒÅËÜÍÎÉ ÒÅÐÀÏÈÈ

®

E. N. Okhotnikova
PECULIARITIES OF RESPIRATORY ALLERGY IN CHILDREN AND ADOLESCENTS AND MODERN ANTI-INFLAMMATORY THERAPY OPTIONS
 

Ë. Â. Þäèíà
ÁÀÇÈÑÍÀß ÒÅÐÀÏÈß ÁÐÎÍÕÈÀËÜÍÎÉ ÀÑÒÌÛ: ÂÛÁÎÐ ÂÑÅÃÄÀ ÅÑÒÜ

®

L. V. Iudina
MAINTENANCE THERAPY OF ASTHMA: AN OPTION ALWAYS EXISTS
 

²ÍÔÎÐÌÀÖ²ß / INFORMATION

 

ÀÂÒÎÐÀÌ ÆÓÐÍÀËÜÍÈÕ ÏÓÁ˲ÊÀÖ²É
®

INSTRUCTIONS TO THE AUTHORS
 

 

 



HomeÏîèñê Ïðî èíñòèòóòÍîâîñòè Íàøè èçäàíèÿ Îðèãèíàëüíûå ñòàòòüè Íîâîââåäåíèÿ
ÏàòåíòûÎò÷åòû î ÍÄÐ Ïîäãîòîâêà êàäðîâ Íàó÷íûå ôîðóìû
Èíôîðìàöèÿ äëÿ ñïåöèàëèñòîâÈíôîðìàöèÿ äëÿ íàñåëåíèÿÌåäèöèíñêèå óñëóãè


© Îòäåë ÈÊÒ
ÍÈÔÏ

Îòïðàâèòü E-mail â Èíñòèòóò

www.ifp.kiev.ua